People
Seth Lundy represents prominent medical device and pharmaceutical companies and healthcare providers, suppliers and distributors in complex legal and regulatory matters and investigations. As Deputy Chair of our FDA and Life Sciences practice, identified by Law360 as Life Sciences Group of the Year for 2016, Seth is widely recognized as a leading national authority on compliance with federal and state fraud and abuse laws. His practical, business-oriented approach earns accolades from sources including Chambers USA, Best Lawyers and Super Lawyers.
Seth's in-depth understanding of the industry allows him to work seamlessly with boards of directors, C-suite management, legal departments, compliance offices and operational divisions. He designs compliance programs; helps client to ensure that operations meet changing standards; defends clients in government investigations; performs internal audits; conducts corporate due diligence; and engages in civil, criminal and administrative litigation.
Seth is experienced in working with federal regulators and legislators to create, revise and interpret healthcare-related laws, regulations and policies. He also develops business and marketing strategies that respond to ever-changing federal regulatory schemes.
A frequent author and speaker on healthcare compliance and investigations, Seth works to help clients to identify and predict burgeoning areas of enforcement. Seth has been recognized since 2008 as a top Washington, D.C. healthcare lawyer by Chambers USA. He has also received recognition as a leading healthcare lawyer from Expert Guides, Guide to the Leading Healthcare Lawyers, Super Lawyers Washington, D.C., Best Lawyers, and Washingtonian Magazine's Top Lawyers rankings.
J.D., George Washington University, with honors
B.A., Amherst College, cum laude
District of Columbia
Maryland
French
September 21, 2023
LMG Life Sciences Recognizes King & Spalding With Multiple Rankings in its 2023 Guide
June 8, 2023
King & Spalding Earns Top-Tier Rankings in Legal 500 United States 2023 Guide
June 1, 2023
Chambers USA 2023 Recognizes 186 K&S Lawyers and 84 K&S Practice Groups as Leaders in Their Fields
April 1, 2023
Chambers Global Practice Guide: Pharmaceutical Advertising 2023
November 18, 2022
DOJ increases scrutiny of arrangements with EHR vendors: what the ModMed settlement means for the life sciences industry
November 7, 2022
DOJ Increases Scrutiny of Arrangements with EHR Vendors: What the ModMed Settlement Means for the Life Sciences Industry
September 21, 2023
LMG Life Sciences Recognizes King & Spalding With Multiple Rankings in its 2023 Guide
June 8, 2023
King & Spalding Earns Top-Tier Rankings in Legal 500 United States 2023 Guide
June 1, 2023
Chambers USA 2023 Recognizes 186 K&S Lawyers and 84 K&S Practice Groups as Leaders in Their Fields
April 1, 2023
Chambers Global Practice Guide: Pharmaceutical Advertising 2023
November 18, 2022
DOJ increases scrutiny of arrangements with EHR vendors: what the ModMed settlement means for the life sciences industry
November 7, 2022
DOJ Increases Scrutiny of Arrangements with EHR Vendors: What the ModMed Settlement Means for the Life Sciences Industry
September 21, 2023
LMG Life Sciences Recognizes King & Spalding With Multiple Rankings in its 2023 Guide
June 8, 2023
King & Spalding Earns Top-Tier Rankings in Legal 500 United States 2023 Guide
June 1, 2023
Chambers USA 2023 Recognizes 186 K&S Lawyers and 84 K&S Practice Groups as Leaders in Their Fields
J.D., George Washington University, with honors
B.A., Amherst College, cum laude
District of Columbia
Maryland
French